Literature DB >> 27366571

Whole Lung Lavage in a Pulmonary Alveolar Proteinosis Patient with Severe Respiratory Failure.

Canan Salman Önemli1, Deniz Ayhan Çatal2.   

Abstract

Pulmonary alveolar proteinosis (PAP) is a rare interstitial lung disease that develops as a result of defects in the clearance of surfactant by alveolar macrophages. The accumulation of lipid- and protein-rich substances in the alveoli constitutes the main pathology of this disease. PAP has three types of aetiology: autoimmune (primary), congenital and secondary. The most common form in adults is autoimmune PAP. Whole lung lavage is a commonly performed method for treatment of this form of disease, especially in more severe cases. Performed under general anaesthesia, the material deposited in the alveoli is removed by washing. In this paper, we present a whole lung lavage under anaesthesia in a PAP patient who had severe respiratory failure.

Entities:  

Keywords:  Whole lung lavage; anaesthesia; pulmonary alveolar proteinosis

Year:  2016        PMID: 27366571      PMCID: PMC4894197          DOI: 10.5152/TJAR.2016.45477

Source DB:  PubMed          Journal:  Turk J Anaesthesiol Reanim        ISSN: 2149-276X


  8 in total

Review 1.  Pulmonary alveolar proteinosis.

Authors:  R Borie; C Danel; M-P Debray; C Taille; M-C Dombret; M Aubier; R Epaud; B Crestani
Journal:  Eur Respir Rev       Date:  2011-06

2.  Pulmonary alveolar proteinosis.

Authors:  S H ROSEN; B CASTLEMAN; A A LIEBOW
Journal:  N Engl J Med       Date:  1958-06-05       Impact factor: 91.245

Review 3.  Pulmonary alveolar proteinosis.

Authors:  Ajmal Khan; Ritesh Agarwal
Journal:  Respir Care       Date:  2011-04-15       Impact factor: 2.258

4.  An uncommon procedure for a rare ailment: massive bronchoalveolar lavage in a patient with pulmonary alveolar proteinosis.

Authors:  Hilal Günal Sazak; Saziye Sahin; Polat Pehlivanoğlu; Ozlem Cakır; Mehtap Tunç; Fatma Ulus; Behiye Akkalyoncu; Belgin Samurkaşoğlu
Journal:  Balkan Med J       Date:  2012-09-01       Impact factor: 2.021

5.  Whole-lung lavage for pulmonary alveolar proteinosis.

Authors:  Gaëtane Michaud; Chakravarthy Reddy; Armin Ernst
Journal:  Chest       Date:  2009-12       Impact factor: 9.410

6.  Duration of benefit in patients with autoimmune pulmonary alveolar proteinosis after inhaled granulocyte-macrophage colony-stimulating factor therapy.

Authors:  Ryushi Tazawa; Yoshikazu Inoue; Toru Arai; Toshinori Takada; Yasunori Kasahara; Masayuki Hojo; Shinya Ohkouchi; Yoshiko Tsuchihashi; Masanori Yokoba; Ryosuke Eda; Hideaki Nakayama; Haruyuki Ishii; Takahito Nei; Konosuke Morimoto; Yasuyuki Nasuhara; Masahito Ebina; Masanori Akira; Toshio Ichiwata; Koichiro Tatsumi; Etsuro Yamaguchi; Koh Nakata
Journal:  Chest       Date:  2014-04       Impact factor: 9.410

7.  Inhaled granulocyte/macrophage-colony stimulating factor as therapy for pulmonary alveolar proteinosis.

Authors:  Ryushi Tazawa; Bruce C Trapnell; Yoshikazu Inoue; Toru Arai; Toshinori Takada; Yasuyuki Nasuhara; Nobuyuki Hizawa; Yasunori Kasahara; Koichiro Tatsumi; Masayuki Hojo; Haruyuki Ishii; Masanori Yokoba; Naohiko Tanaka; Etsuro Yamaguchi; Ryosuke Eda; Yoshiko Tsuchihashi; Konosuke Morimoto; Masanori Akira; Masaki Terada; Junji Otsuka; Masahito Ebina; Chinatsu Kaneko; Toshihiro Nukiwa; Jeffrey P Krischer; Kohei Akazawa; Koh Nakata
Journal:  Am J Respir Crit Care Med       Date:  2010-02-18       Impact factor: 21.405

8.  Pulmonary alveolar proteinosis: diagnostic and therapeutic challenges.

Authors:  Ilaria Campo; Zamir Kadija; Francesca Mariani; Elena Paracchini; Giuseppe Rodi; Francesco Mojoli; Antonio Braschi; Maurizio Luisetti
Journal:  Multidiscip Respir Med       Date:  2012-06-11
  8 in total
  1 in total

1.  Whole-lung lavage in a patient with pulmonary alveolar proteinosis.

Authors:  Lindsay R Hunter Guevara; Shane M Gillespie; Alan M Klompas; Norman E Torres; David W Barbara
Journal:  Ann Card Anaesth       Date:  2018 Apr-Jun
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.